Cargando…
Regulatory T cell therapy suppresses inflammation of oral mucosa
Oral inflammatory diseases, including oral lichen planus (OLP) and recurrent aphthous ulcer (RAU), seriously affect the patient’s quality of life. Due to the lack of ideal disease models, it is difficult to determine whether novel immunotherapy strategies are effective in treating oral inflammatory...
Autores principales: | Xue, Ningning, Wang, Ying, Cheng, Hao, Liang, Hantian, Fan, Xinzou, Zuo, Fengqiong, Zeng, Xin, Ji, Ning, Chen, Qianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660253/ https://www.ncbi.nlm.nih.gov/pubmed/36389752 http://dx.doi.org/10.3389/fimmu.2022.1009742 |
Ejemplares similares
-
Excessive intake of sugar: An accomplice of inflammation
por: Ma, Xiao, et al.
Publicado: (2022) -
Targeting Th17 cells: a promising strategy to treat oral mucosal inflammatory diseases
por: Wang, Ying, et al.
Publicado: (2023) -
Interactions between neutrophils and T-helper 17 cells
por: Fan, Xinzou, et al.
Publicado: (2023) -
Celiac Disease Causes Epithelial Disruption and Regulatory T Cell Recruitment in the Oral Mucosa
por: Sanchez-Solares, Javier, et al.
Publicado: (2021) -
Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates
por: Tang, Mei, et al.
Publicado: (2022)